BAXTER: Obtains U.S. FDA Emergency Use Authorization for Regiocit Replacement Solution Used in CRRT
Only authorized citrate-based replacement solution available in the U.S. for use in continuous renal replacement therapy (CRRT) during COVID-19 pandemic